President Biden today directed the Center for Medicare and Medicaid Innovation to consider new payment and delivery models to lower drug costs and promote access to innovative drug therapies for beneficiaries, and report within 90 days on its plan and timeline for testing selected models. AHA will update members as more information on the plan becomes available.
 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services March 28 issued a proposed rule for fiscal year 2025 for the skilled nursing facility prospective payment…
Headline
This April through June under the Inflation Reduction Act, Medicare will reduce the coinsurance amount for 41 Part B prescription drugs from 20% to somewhere…
Headline
The Department of Health and Human Services’ Advanced Research Projects Agency (ARPA-H) has released a draft solicitation for applicants to the Health Care…
Headline
AHA March 19 urged the Centers for Medicare & Medicaid Services to modernize its high-cost outlier policy for the long-term care hospital prospective…
Headline
The Centers for Medicare & Medicaid Services expects to launch a voluntary primary care model in January 2025 for low-revenue accountable care…
Headline
AHA March 18 shared with the House Ways and Means Committee its proposals to strengthen access to timely emergency medical care, particularly in rural and…